OneMedNet (NASDAQ: ONMD, ONMDW), the leading curator of regulatory-grade Imaging Real World Data (“iRWD”) through its proven OneMedNet iRWD(TM) solution, has entered into a standby equity purchase agreement (“SEPA”) with YA II PN, Ltd, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP. According to the forms filed with the U.S. Security and Exchange Commission, OneMedNet the option to sell to Yorkville up to $25 million of the company’s shares of common stock, par value $0.0001 per share “at the company’s request from time to time following both the repayment of the promissory note. . . and the effectiveness of a resale registration statement covering the shares of issued under the SEPA. The SEPA terminates on its 24-month anniversary.” The company also paid a $25,000 structuring fee to Yorkville and agreed to pay a commitment fee of $500,000 to Yorkville; that payment will be paid in shares in two tranches. EF Hutton served as exclusive placement agent on the transaction. EF Hutton served as exclusive placement agent on the $1.5 million private placement.
For more information, visit https://ibn.fm/z5LrQ
About OneMedNet Corporation
Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data (“RWD”) repositories of more than 1,400 healthcare system and provider sites that currently comprise its iRWD(TM) network. OneMedNet’s proprietary iRWD platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results and uniquely medical imaging. Employing its robust OneMedNet iRWD solution, OneMedNet securely deidentifies, searches and curates the clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic artificial intelligence (“AI”) development customers. OneMedNet’s platform is designed to meet the clinical requirement necessary across various domains, including but not limited to rare diseases, oncology and cardiology. The company is committed to delivering precise and robust research support services that span the entire continuum of care. This commitment is a cornerstone of OneMedNet’s strategy to enhance patient outcomes and help pave the next wave of healthcare innovation. For more information about the company, please visit www.OneMedNet.com.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
